ERBB2 and triple-negative breast carcinoma: As indicated by large‐scale adjuvant studies, in primary biopsy the higher TIL levels have been shown to be associated with reduced recurrence and improved overall survival (OS) particularly in cases with triple negative breast cancer (TNBC), the HER2‐positive, and the human epidermal growth factor receptor 2.11, 12, 13